2023-24 Academic Calendar (PDF)2024-25 Academic Calendar (PDF)
« All Events
You are invited to the continuation of KGI’s 25th Anniversary Speaker Series, as part of the Institute’s 25th Anniversary, featuring Dr. Kiana Aran, who will discuss “My Journey in Finding my Freedom through Science.” Moderated by Paul Grint, Executive Chairman of Cardea Bio, hear about her incredible journey from Iran to KGI, her science and inventions, and her efforts to support women in STEM by founding the Aran Nebula Foundation.
Alumni, students, staff, faculty, parents, and corporate partners are invited! Refreshments sponsored by KGI. Please RSVP below.
Location: Joya Kitchen, 10275 Science Center Dr #150, San Diego, CA 92121
Dr. Kiana Aran is an Iranian/American biomedical entrepreneur who is an associate professor of bioengineering at KGI and co-founder and chief scientific officer at Cardea Bio, a biotechnology company developing next-generation bio-integrated electronic chips for precision medicine. She is also the technical co-founder of CRISPR QC, a biotechnology company that develops analytical tools for CRISPR, and is a pioneer of combining CRISPR with modern electronics.
Aran is a recipient of the National Institutes of Health postdoctoral training fellowship at the Buck Institute for Age Research and is a consultant for the Gates Foundation. Her efforts have been recognized within the scientific community by the Clinical OMICs 10 under 40 Award, Athena Pinnacle Award in Life Sciences, NSF Career award, Nature Research Awards for Inspiring Women in Science: Scientific Achievement Category’s Overall Winner in 2021, and Distinguished Engineering Medal of Excellence from Rutgers University in 2022. Aran also received multiple NIH RO1, DARPA, and Gate Foundation grants and awards from the private sector to develop the next generation of electronic biosensors for precision medicine.
Aran’s research focuses on designing novel bio-integrated electronic platforms, using 2D nanomaterials, for precision medicine and utilizing biology as tech elements for various biosensing applications. In addition to biosensing, she combines various engineering modules to develop tools to understand the aging process better. Aran’s scientific vision is to explore the utility of nano-electronic systems to develop transformative and customizable platforms for multi-omics applications and the commercialization of these platforms.
She received her undergraduate degree in electrical engineering from the City University of New York in 2007 and her PhD in Biomedical Engineering from Rutgers University in 2012. She then continued her postdoctoral studies in bioengineering at the University of California, Berkeley. She received the National Institutes of Health (NIH) postdoctoral training fellowship at the Buck Institute for Aging Research in 2015.
Dr. Paul Grint was most recently CEO and a member of the board of directors of AmpliPhi Biosciences, which merged with C3J Therapeutics to form Armata Pharmaceuticals. Grint has more than two decades of experience in biologics and small-molecule research and development, including the successful approval and commercialization of products in the infectious diseases, immunology, and oncology therapeutic areas. Grint has also served in senior management roles at Cerexa, Forest Laboratories, Kalypsys, Pfizer, IDEC Pharmaceuticals, and Schering-Plough Corporation.
Grint is currently the executive chairman of Cardea Bio and a board member at Amplyx Pharmaceuticals, Inhibikase Therapeutics, and Synedgen. He is a Fellow of the Royal College of Pathologists, a member of numerous professional and medical societies, and holds a bachelor’s degree from St. Mary’s Hospital College, University of London, and a medical degree from St. Bartholomew’s Hospital College, University of London.